Immunocore Holdings plc (IMCR)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$1.12B
Stockholders' Equity
$419.8M
Cash & Equivalents
$484.9M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Immunocore Holdings plc reported revenue of $115.9M, net income of -$808,000, and total assets of $1.12B. Every figure below is taken directly from Immunocore Holdings plc's SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2021–FY2025 · as reported

$400.0M$110.0M-$180.0M
FY2021FY2022FY2023FY2024FY2025
Revenue$400.0MNet income-$35.5M
FY2021 revenue
$36.5M
FY2025 revenue
$400.0M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$400.0M-$35.5M
FY2024$310.2M-$51.1M
FY2023$249.4M-$55.3M
FY2022$174.4M-$52.5M
FY2021$36.5M-$180.0M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KSep 14, 2026on EDGAR ↗
8-KAug 6, 2026on EDGAR ↗
10-QAug 6, 2026on EDGAR ↗
8-KMay 27, 2026on EDGAR ↗
8-KMay 6, 2026on EDGAR ↗
10-QMay 6, 2026on EDGAR ↗
DEF 14AApr 16, 2026on EDGAR ↗
8-KFeb 25, 2026on EDGAR ↗
10-KFeb 25, 2026on EDGAR ↗
8-KJan 30, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$1.12Bsource ↗
Stockholders’ Equity$419.8Msource ↗
Cash & Equivalents$484.9Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$115.9Msource ↗
Net Income-$808,000source ↗
Operating Income-$3.0Msource ↗
Gross Profit$114.8Msource ↗
Cost of Revenue$1.1Msource ↗
R&D Expense$73.9Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.02source ↗
EPS (basic)$-0.02source ↗
Shares Outstanding51.5Msource ↗
Cash from Operations$15.9Msource ↗
Cash from Financing$16.5Msource ↗
Cash from Investing-$786,000source ↗

Insider activity

Form 4 open-market activity, last 180 days

No open-market Form 4 transactions filed in the last 180 days.

Restatement history

Point-in-time

No material restatements detected across 132 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches IMCR’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/IMCR

MCP tool: get_sec_fundamentals ticker=IMCR

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/IMCR/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=IMCR as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/IMCR/history

MCP tool: get_fundamentals_history ticker=IMCR

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/IMCR

MCP tool: get_financial_health ticker=IMCR

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.